Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of -62.65 is 60759% below its 5-year average of -0.10, near the low end of its 5-year range (-62.65–4.21).
As of the fiscal period ended Tuesday, June 30, 2026. 338.85% below its 12-month average of -14.28.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): -62.65.
DEBT TO EQUITY RATIO
-62.65
DEBT TO EQUITY RATIO AVG TTM
-14.28
DEBT TO EQUITY RATIO AVG 3Y
0.74
DEBT TO EQUITY RATIO AVG 5Y
-0.10
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-338.85%
CURRENT VS 3Y AVG
-8558.74%
CURRENT VS 5Y AVG
-60758.88%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 716 covered companies
CURRENT VS SECTOR MEDIAN
-57057.28%
vs the sector median at left
Adagio Medical Holdings, Inc.
Market Cap
$3.02M
Debt to Equity Ratio
-62.65
TTM Avg
-14.28
3Y Avg
0.74
5Y Avg
-0.10
Market Cap
$3.03M
Debt to Equity Ratio
0.07
TTM Avg
0.04
3Y Avg
0.02
5Y Avg
0.02
Market Cap
$3.01M
Debt to Equity Ratio
0.01
TTM Avg
0.00
3Y Avg
0.01
5Y Avg
0.02
Market Cap
$3.09M
Debt to Equity Ratio
0.01
TTM Avg
0.05
3Y Avg
0.04
5Y Avg
0.04
Market Cap
$3.27M
Debt to Equity Ratio
0.02
TTM Avg
0.06
3Y Avg
0.17
5Y Avg
0.12
Market Cap
$3.29M
Debt to Equity Ratio
0.07
TTM Avg
0.10
3Y Avg
0.11
5Y Avg
0.08
Market Cap
$3.35M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | $3.02M | -62.65 | -14.28 | 0.74 | -0.10 |
| Revelation Biosciences, Inc. (REVB)vs › | $3.03M | 0.07 | 0.04 | 0.02 | 0.02 |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.01M | 0.01 | 0.00 | 0.01 | 0.02 |
| IceCure Medical Ltd (ICCM)vs › | $3.09M | 0.01 | 0.05 | 0.04 | 0.04 |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 0.00 | 0.00 | 0.01 | 0.01 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.27M | 0.02 | 0.06 | 0.17 | 0.12 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | 0.07 | 0.10 | 0.11 | 0.08 |
| iSpecimen Inc. (ISPC)vs › | $2.72M | 0.14 | 0.09 | 0.05 | 0.06 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.35M | 0.00 | 0.00 | 0.00 | 0.00 |
| Nuwellis, Inc. (NUWE)vs › | $2.63M | N/A | 0.11 | 0.13 | 0.10 |
Debt/Equity
-62.65
Current Ratio
1.41
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | -62.65 |
| 2026-03-31 | 4.21 |
| 2025-12-31 | 1.75 |
| 2025-09-30 | -16.74 |
| 2025-06-30 | 2.05 |
| 2025-03-31 | 1.50 |
| 2024-12-31 | 0.82 |
| 2024-09-30 | 0.18 |
| 2024-06-30 | -0.92 |
| 2024-03-31 | -0.96 |
| 2023-12-31 | -0.29 |
| 2023-09-30 | -0.24 |
| 2023-06-30 | 0.04 |
| 2023-03-31 | 0.03 |
| 2022-12-31 | -0.10 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.00 |
| 2021-09-30 | 0.00 |
